HTA143 Are HTA Agencies Willing to Accept Single-Arm Trials as the Main Source of Clinical Evidence for the Assessment of Pediatric Orphan Drugs When Faced With Extenuating Ethical and Medical Circumstances?
- Resource Type
- Abstract
- Source
- In
Value in Health December 2022 25(12) Supplement:S324-S324 - Subject
- Language
- ISSN
- 1098-3015